Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 483

1.

Systemic Infection of Nicotiana benthamiana with Potato virus X Nanoparticles Presenting a Fluorescent iLOV Polypeptide Fused Directly to the Coat Protein.

Röder J, Dickmeis C, Fischer R, Commandeur U.

Biomed Res Int. 2018 Feb 13;2018:9328671. doi: 10.1155/2018/9328671. eCollection 2018.

2.

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients.

Fidler MJ, Fhied CL, Roder J, Basu S, Sayidine S, Fughhi I, Pool M, Batus M, Bonomi P, Borgia JA.

BMC Cancer. 2018 Mar 20;18(1):310. doi: 10.1186/s12885-018-4193-0.

3.

Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy.

Grossi F, Genova C, Rijavec E, Barletta G, Biello F, Dal Bello MG, Meyer K, Roder J, Roder H, Grigorieva J.

Lung Cancer. 2018 Mar;117:64-69. doi: 10.1016/j.lungcan.2017.12.007. Epub 2017 Dec 13.

4.

A Serum Protein Signature Associated with Outcome after Anti-PD-1 Therapy in Metastatic Melanoma.

Weber JS, Sznol M, Sullivan RJ, Blackmon S, Boland G, Kluger HM, Halaban R, Bacchiocchi A, Ascierto PA, Capone M, Oliveira C, Meyer K, Grigorieva J, Asmellash SG, Roder J, Roder H.

Cancer Immunol Res. 2018 Jan;6(1):79-86. doi: 10.1158/2326-6066.CIR-17-0412. Epub 2017 Dec 5.

PMID:
29208646
5.

Engineering Potato Virus X Particles for a Covalent Protein Based Attachment of Enzymes.

Röder J, Fischer R, Commandeur U.

Small. 2017 Dec;13(48). doi: 10.1002/smll.201702151. Epub 2017 Nov 10.

PMID:
29125698
6.

Engineered Potato virus X nanoparticles support hydroxyapatite nucleation for improved bone tissue replacement.

Lauria I, Dickmeis C, Röder J, Beckers M, Rütten S, Lin YY, Commandeur U, Fischer H.

Acta Biomater. 2017 Oct 15;62:317-327. doi: 10.1016/j.actbio.2017.08.039. Epub 2017 Aug 30.

PMID:
28864253
7.

Adoption of the 2A Ribosomal Skip Principle to Tobacco Mosaic Virus for Peptide Display.

Röder J, Fischer R, Commandeur U.

Front Plant Sci. 2017 Jun 28;8:1125. doi: 10.3389/fpls.2017.01125. eCollection 2017.

8.

Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.

McGirr A, Lipina TV, Mun HS, Georgiou J, Al-Amri AH, Ng E, Zhai D, Elliott C, Cameron RT, Mullins JG, Liu F, Baillie GS, Clapcote SJ, Roder JC.

Neuropsychopharmacology. 2017 Apr;42(5):1178. doi: 10.1038/npp.2016.263. No abstract available.

9.

Ex situ groundwater treatment triggering the mobilization of geogenic uranium from aquifer sediments.

Banning A, Pawletko N, Röder J, Kübeck C, Wisotzky F.

Sci Total Environ. 2017 Jun 1;587-588:371-380. doi: 10.1016/j.scitotenv.2017.02.162. Epub 2017 Feb 23.

PMID:
28237470
10.

Charge states and lattice sites of dilute implanted Sn in ZnO.

Mølholt TE, Gunnlaugsson HP, Johnston K, Mantovan R, Röder J, Adoons V, Mokhles Gerami A, Masenda H, Matveyev YA, Ncube M, Unzueta I, Bharuth-Ram K, Gislason HP, Krastev P, Langouche G, Naidoo D, Ólafsson S, Zenkevich A.

J Phys Condens Matter. 2017 Apr 20;29(15):155701. doi: 10.1088/1361-648X/aa5e95. Epub 2017 Feb 6.

PMID:
28165333
11.

Predictors of elevational biodiversity gradients change from single taxa to the multi-taxa community level.

Peters MK, Hemp A, Appelhans T, Behler C, Classen A, Detsch F, Ensslin A, Ferger SW, Frederiksen SB, Gebert F, Haas M, Helbig-Bonitz M, Hemp C, Kindeketa WJ, Mwangomo E, Ngereza C, Otte I, Röder J, Rutten G, Schellenberger Costa D, Tardanico J, Zancolli G, Deckert J, Eardley CD, Peters RS, Rödel MO, Schleuning M, Ssymank A, Kakengi V, Zhang J, Böhning-Gaese K, Brandl R, Kalko EK, Kleyer M, Nauss T, Tschapka M, Fischer M, Steffan-Dewenter I.

Nat Commun. 2016 Dec 22;7:13736. doi: 10.1038/ncomms13736.

12.

Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.

Grossi F, Rijavec E, Genova C, Barletta G, Biello F, Maggioni C, Burrafato G, Sini C, Dal Bello MG, Meyer K, Roder J, Roder H, Grigorieva J.

Br J Cancer. 2017 Jan 3;116(1):36-43. doi: 10.1038/bjc.2016.387. Epub 2016 Nov 29.

13.

Deficits in social behavioral tests in a mouse model of alternating hemiplegia of childhood.

Kirshenbaum GS, Idris NF, Dachtler J, Roder JC, Clapcote SJ.

J Neurogenet. 2016 Mar;30(1):42-9. doi: 10.1080/01677063.2016.1182525.

14.

Neuronal calcium sensor-1 deletion in the mouse decreases motivation and dopamine release in the nucleus accumbens.

Ng E, Varaschin RK, Su P, Browne CJ, Hermainski J, Le Foll B, Pongs O, Liu F, Trudeau LE, Roder JC, Wong AH.

Behav Brain Res. 2016 Mar 15;301:213-25. doi: 10.1016/j.bbr.2015.12.037. Epub 2015 Dec 29.

PMID:
26738968
15.

Ultrasonic Vocalizations in Mice During Exploratory Behavior are Context-Dependent.

Mun HS, Lipina TV, Roder JC.

Front Behav Neurosci. 2015 Dec 10;9:316. doi: 10.3389/fnbeh.2015.00316. eCollection 2015.

16.

Self-directed exploration provides a Ncs1-dependent learning bonus.

Mun HS, Saab BJ, Ng E, McGirr A, Lipina TV, Gondo Y, Georgiou J, Roder JC.

Sci Rep. 2015 Dec 7;5:17697. doi: 10.1038/srep17697.

17.

Characterization of cognitive deficits in mice with an alternating hemiplegia-linked mutation.

Kirshenbaum GS, Dachtler J, Roder JC, Clapcote SJ.

Behav Neurosci. 2015 Dec;129(6):822-31. doi: 10.1037/bne0000097. Epub 2015 Oct 26.

18.

Disruption of Src Is Associated with Phenotypes Related to Williams-Beuren Syndrome and Altered Cellular Localization of TFII-I

Sinai L, Ivakine EA, Lam E, Deurloo M, Dida J, Zirngibl RA, Jung C, Aubin JE, Feng ZP, Yeomans J, McInnes RR, Osborne LR, Roder JC.

eNeuro. 2015 Mar 30;2(2). pii: ENEURO.0016-14.2015. doi: 10.1523/ENEURO.0016-14.2015. eCollection 2015 Mar-Apr.

19.

Transgenic rescue of phenotypic deficits in a mouse model of alternating hemiplegia of childhood.

Kirshenbaum GS, Dachtler J, Roder JC, Clapcote SJ.

Neurogenetics. 2016 Jan;17(1):57-63. doi: 10.1007/s10048-015-0461-1. Epub 2015 Oct 13.

20.

Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.

McGirr A, Lipina TV, Mun HS, Georgiou J, Al-Amri AH, Ng E, Zhai D, Elliott C, Cameron RT, Mullins JG, Liu F, Baillie GS, Clapcote SJ, Roder JC.

Neuropsychopharmacology. 2016 Mar;41(4):1080-92. doi: 10.1038/npp.2015.240. Epub 2015 Aug 14.

21.

Cognitive Deficits in Calsyntenin-2-deficient Mice Associated with Reduced GABAergic Transmission.

Lipina TV, Prasad T, Yokomaku D, Luo L, Connor SA, Kawabe H, Wang YT, Brose N, Roder JC, Craig AM.

Neuropsychopharmacology. 2016 Feb;41(3):802-10. doi: 10.1038/npp.2015.206. Epub 2015 Jul 14.

22.

Hippocampal place cell and inhibitory neuron activity in Disrupted-in-schizophrenia-1 mutant mice: implications for working memory deficits.

Mesbah-Oskui L, Georgiou J, Roder JC.

NPJ Schizophr. 2015 Apr 1;1. pii: doi:10.1038/npjschz.2015.11.

23.

A Far-Red Emitting Probe for Unambiguous Detection of Mobile Zinc in Acidic Vesicles and Deep Tissue.

Rivera-Fuentes P, Wrobel AT, Zastrow ML, Khan M, Georgiou J, Luyben TT, Roder JC, Okamoto K, Lippard SJ.

Chem Sci. 2015;6(3):1944-1948.

24.

Hippocampal place cell and inhibitory neuron activity in disrupted-in-schizophrenia-1 mutant mice: implications for working memory deficits.

Mesbah-Oskui L, Georgiou J, Roder JC.

NPJ Schizophr. 2015 Apr 1;1:15011. doi: 10.1038/npjschz.2015.11. eCollection 2015.

PMID:
27336029
25.

A dopamine D2 receptor-DISC1 protein complex may contribute to antipsychotic-like effects.

Su P, Li S, Chen S, Lipina TV, Wang M, Lai TK, Lee FH, Zhang H, Zhai D, Ferguson SS, Nobrega JN, Wong AH, Roder JC, Fletcher PJ, Liu F.

Neuron. 2014 Dec 17;84(6):1302-16. doi: 10.1016/j.neuron.2014.11.007. Epub 2014 Nov 26.

26.

The mechanically induced structural disorder in barium hexaferrite, BaFe12O19, and its impact on magnetism.

Sepelák V, Myndyk M, Witte R, Röder J, Menzel D, Schuster RH, Hahn H, Heitjans P, Becker KD.

Faraday Discuss. 2014;170:121-35. doi: 10.1039/c3fd00137g.

PMID:
25406482
27.

Multicenter double-blinded randomized controlled trial of standard abdominal wound edge protection with surgical dressings versus coverage with a sterile circular polyethylene drape for prevention of surgical site infections: a CHIR-Net trial (BaFO; NCT01181206).

Mihaljevic AL, Schirren R, Özer M, Ottl S, Grün S, Michalski CW, Erkan M, Jäger C, Reiser-Erkan C, Kehl V, Schuster T, Roder J, Clauer U, Orlitsch C, Hoffmann TF, Lange R, Harzenetter T, Steiner P, Michalski M, Henkel K, Stadler J, Pistorius GA, Jahn A, Obermaier R, Unger R, Strunk R, Willeke F, Vogelsang H, Halve B, Dietl KH, Hilgenstock H, Meyer A, Krämling HJ, Wagner M, Schoenberg MH, Zeller F, Schmidt J, Friess H, Kleeff J.

Ann Surg. 2014 Nov;260(5):730-7; discussion 737-9. doi: 10.1097/SLA.0000000000000954.

PMID:
25379844
28.

[Morbidity, mortality and analysis of prognostic factors for colorectal cancer].

Clauer U, Schäfer J, Roder J.

Chirurg. 2015 Jun;86(6):561-9. doi: 10.1007/s00104-014-2867-y. German.

PMID:
25234503
29.

Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: impact of mouse models.

Lipina TV, Roder JC.

Neurosci Biobehav Rev. 2014 Sep;45:271-94. doi: 10.1016/j.neubiorev.2014.07.001. Epub 2014 Jul 9. Review.

PMID:
25016072
30.

Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial.

Gregorc V, Novello S, Lazzari C, Barni S, Aieta M, Mencoboni M, Grossi F, De Pas T, de Marinis F, Bearz A, Floriani I, Torri V, Bulotta A, Cattaneo A, Grigorieva J, Tsypin M, Roder J, Doglioni C, Levra MG, Petrelli F, Foti S, Viganò M, Bachi A, Roder H.

Lancet Oncol. 2014 Jun;15(7):713-21. doi: 10.1016/S1470-2045(14)70162-7. Epub 2014 May 13.

31.

Two-photon imaging of Zn2+ dynamics in mossy fiber boutons of adult hippocampal slices.

Khan M, Goldsmith CR, Huang Z, Georgiou J, Luyben TT, Roder JC, Lippard SJ, Okamoto K.

Proc Natl Acad Sci U S A. 2014 May 6;111(18):6786-91. doi: 10.1073/pnas.1405154111. Epub 2014 Apr 22.

32.

DISC1 as a genetic risk factor for schizophrenia and related major mental illness: response to Sullivan.

Porteous DJ, Thomson PA, Millar JK, Evans KL, Hennah W, Soares DC, McCarthy S, McCombie WR, Clapcote SJ, Korth C, Brandon NJ, Sawa A, Kamiya A, Roder JC, Lawrie SM, McIntosh AM, St Clair D, Blackwood DH.

Mol Psychiatry. 2014 Feb;19(2):141-3. doi: 10.1038/mp.2013.160. No abstract available.

33.

α7nAchR/NMDAR coupling affects NMDAR function and object recognition.

Li S, Nai Q, Lipina TV, Roder JC, Liu F.

Mol Brain. 2013 Dec 20;6:58. doi: 10.1186/1756-6606-6-58.

34.

Attenuation of mania-like behavior in Na(+),K(+)-ATPase α3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise.

Kirshenbaum GS, Burgess CR, Déry N, Fahnestock M, Peever JH, Roder JC.

Neuroscience. 2014 Feb 28;260:195-204. doi: 10.1016/j.neuroscience.2013.12.011. Epub 2013 Dec 14.

PMID:
24342563
35.

Maternal immune activation during gestation interacts with Disc1 point mutation to exacerbate schizophrenia-related behaviors in mice.

Lipina TV, Zai C, Hlousek D, Roder JC, Wong AH.

J Neurosci. 2013 May 1;33(18):7654-66. doi: 10.1523/JNEUROSCI.0091-13.2013.

36.

Abnormal interneuron development in disrupted-in-schizophrenia-1 L100P mutant mice.

Lee FH, Zai CC, Cordes SP, Roder JC, Wong AH.

Mol Brain. 2013 Apr 30;6:20. doi: 10.1186/1756-6606-6-20.

37.

Using rodents to model schizophrenia and substance use comorbidity.

Ng E, McGirr A, Wong AH, Roder JC.

Neurosci Biobehav Rev. 2013 Jun;37(5):896-910. doi: 10.1016/j.neubiorev.2013.03.025. Epub 2013 Apr 6. Review.

PMID:
23567519
38.

Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase α3 missense mutant mice.

Kirshenbaum GS, Dawson N, Mullins JG, Johnston TH, Drinkhill MJ, Edwards IJ, Fox SH, Pratt JA, Brotchie JM, Roder JC, Clapcote SJ.

PLoS One. 2013;8(3):e60141. doi: 10.1371/journal.pone.0060141. Epub 2013 Mar 20.

39.

A retrospective analysis of VeriStrat status on outcome of a randomized phase II trial of first-line therapy with gemcitabine, erlotinib, or the combination in elderly patients (age 70 years or older) with stage IIIB/IV non-small-cell lung cancer.

Stinchcombe TE, Roder J, Peterman AH, Grigorieva J, Lee CB, Moore DT, Socinski MA.

J Thorac Oncol. 2013 Apr;8(4):443-51. doi: 10.1097/JTO.0b013e3182835577. Erratum in: J Thorac Oncol. 2013 Jun;8(6):814.

40.

Prophylactic valproic acid treatment prevents schizophrenia-related behaviour in Disc1-L100P mutant mice.

Lipina TV, Haque FN, McGirr A, Boutros PC, Berger T, Mak TW, Roder JC, Wong AH.

PLoS One. 2012;7(12):e51562. doi: 10.1371/journal.pone.0051562. Epub 2012 Dec 18.

41.

Active learning for convenient annotation and classification of secondary ion mass spectrometry images.

Hanselmann M, Röder J, Köthe U, Renard BY, Heeren RM, Hamprecht FA.

Anal Chem. 2013 Jan 2;85(1):147-55. doi: 10.1021/ac3023313. Epub 2012 Dec 13.

PMID:
23157438
42.

[Late complications following blunt abdominal and thoracic trauma: two case reports of a minimally invasive therapy].

Lang M, Krumrey MT, Roder J, Ulmer J, Friederichs J, Bühren V.

Chirurg. 2012 Dec;83(12):1078-81. doi: 10.1007/s00104-012-2372-0. German. No abstract available.

PMID:
23142996
43.

VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.

Gautschi O, Dingemans AM, Crowe S, Peters S, Roder H, Grigorieva J, Roder J, Zappa F, Pless M, Brutsche M, Baty F, Bubendorf L, Hsu Schmitz SF, Na KJ, Carbone D, Stahel R, Smit E.

Lung Cancer. 2013 Jan;79(1):59-64. doi: 10.1016/j.lungcan.2012.10.006. Epub 2012 Nov 1.

PMID:
23122759
44.

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

Kuiper JL, Lind JS, Groen HJ, Roder J, Grigorieva J, Roder H, Dingemans AM, Smit EF.

Br J Cancer. 2012 Nov 20;107(11):1820-5. doi: 10.1038/bjc.2012.470. Epub 2012 Oct 18.

45.

Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trial.

Carbone DP, Ding K, Roder H, Grigorieva J, Roder J, Tsao MS, Seymour L, Shepherd FA.

J Thorac Oncol. 2012 Nov;7(11):1653-60. doi: 10.1097/JTO.0b013e31826c1155.

46.
47.

Hyperthermophilic endoglucanase for in planta lignocellulose conversion.

Klose H, Röder J, Girfoglio M, Fischer R, Commandeur U.

Biotechnol Biofuels. 2012 Aug 28;5(1):63. doi: 10.1186/1754-6834-5-63.

48.

[Surgery of gastric cancer in a medium volume center].

Wahnschaff F, Clauer U, Roder J.

Chirurg. 2012 Sep;83(9):823-9. doi: 10.1007/s00104-012-2324-8. German.

PMID:
22821091
49.

Co-learning facilitates memory in mice: a new avenue in social neuroscience.

Lipina TV, Roder JC.

Neuropharmacology. 2013 Jan;64:283-93. doi: 10.1016/j.neuropharm.2012.06.054. Epub 2012 Jul 6.

PMID:
22776545
50.

Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice.

Lipina TV, Palomo V, Gil C, Martinez A, Roder JC.

Neuropharmacology. 2013 Jan;64:205-14. doi: 10.1016/j.neuropharm.2012.06.032. Epub 2012 Jun 28.

PMID:
22749842

Supplemental Content

Support Center